| Stereochemistry | ABSOLUTE |
| Molecular Formula | C5H10O5 |
| Molecular Weight | 150.1299 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H](O)[C@H](O)[C@@H](O)C=O
InChI
InChIKey=PYMYPHUHKUWMLA-VAYJURFESA-N
InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4-,5+/m0/s1
| Molecular Formula | C5H10O5 |
| Molecular Weight | 150.1299 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 3 / 3 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
L-Arabinose is a monosaccharide extracted from plant gums, corn fiber and beet pulps. It is a poorly-absorbed, readily-available sweet-tasting pentose. L-Arabinose is known to suppress obesity by regulating the fasting blood glucose level and the insulin resistance index. L-arabinose is a non-caloric sugar. L-arabinose may inhibit intestinal sucrase activity and thereby delay sucrose digestion.
CNS Activity
Approval Year
Sample Use Guides
1,000 mg of l-arabinose and 200 ug of a patented food source chromium once daily.
Route of Administration:
Oral
Caco-2 cells were cultured for 21 d, homogenized, and used as an enzyme preparation with sucrose as substrate in concentrations from 7 to 280 mmol/L with 0.84, 1.4, and 2.8 mmol L-arabinose/L as inhibitor. The addition of L-arabinose resulted in uncompetitive inhibition of sucrase activity on 25%, 29%, and 38%, respectively.
